inflammatory skin diseases

JAK Inhibitors in Dermatology Patients With Skin of Color
Dr. Brett King discussing the clinical use and safety of JAK inhibitors for treating inflammatory skin conditions in patients with skin of color.Dermatologists must become comfortable prescribing JAK inhibitors in patients with skin of color in order to provide high-quality dermatologic care. That’s according to Dr. Brett King, a dermatologist in Fairfield, Conn., who was the first dermatologist to show that JAK inhibitors as a medicine class were effective in treating a spectrum of dermatologic conditions, including alopecia areata and …
Dr. Brett King discussing the clinical use and safety of JAK inhibitors for treating inflammatory skin conditions in patients with skin of color.
No Brainer Approaches to Neutrophilic Dermatoses
Neutrophilic DermatosesAt the 2025 ODAC Dermatology conference, Dr. Anthony Fernandez, MD, PhD gave an informative presentation titled, No-Brainer Approaches to Neutrophilic Dermatoses. His presentation focused on discussing the clinical presentation, differential diagnosis considerations, and treatment options of pyoderma gangrenosum and Sweet syndrome. Pyoderma Gangrenosum (PG) Pyoderma gangrenosum typically present …
Neutrophilic Dermatoses